KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Treasury Shares (2016 - 2025)

Evolent Health has reported Treasury Shares over the past 6 years, most recently at $61.4 million for Q4 2025.

  • Quarterly results put Treasury Shares at $61.4 million for Q4 2025, up 190.82% from a year ago — trailing twelve months through Dec 2025 was $61.4 million (up 190.82% YoY), and the annual figure for FY2025 was $61.4 million, up 190.82%.
  • Treasury Shares for Q4 2025 was $6.0 million at Evolent Health, roughly flat from $6.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for EVH hit a ceiling of $6.3 million in Q4 2023 and a floor of $1.5 million in Q1 2021.
  • Median Treasury Shares over the past 5 years was $1.5 million (2021), compared with a mean of $2.5 million.
  • Biggest five-year swings in Treasury Shares: changed 0.0% in 2021 and later skyrocketed 190.83% in 2025.
  • Evolent Health's Treasury Shares stood at $21.1 million in 2021, then changed by 0.0% to $21.1 million in 2022, then changed by 0.0% to $21.1 million in 2023, then changed by 0.0% to $21.1 million in 2024, then skyrocketed by 190.82% to $61.4 million in 2025.
  • The last three reported values for Treasury Shares were $61.4 million (Q4 2025), $61.4 million (Q3 2025), and $21.1 million (Q2 2025) per Business Quant data.